• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Neurology

Higher peak expiratory flow associated with decreased headache risk in middle-aged and older adults

bySiwen LiuandAlex Chan
August 25, 2025
in Neurology, Pulmonology
Reading Time: 2 mins read
Significant number of wrong-patient errors in radiology reports
Share on FacebookShare on Twitter

1. Higher peak expiratory flow was associated with a lower probability and lower risk of headache in middle-aged and older adults. 

Evidence Rating Level: 2 (Good)

Headache is a common symptom of patients with chronic lung disease (CLD). Peak expiratory flow (PEF) is the maximum instantaneous flow rate during forced expiration in a forced vital capacity maneuver and serves as an important measure of lung function. The relationship between lung function and headache risk is unclear. This study thus investigated the association between lung function and headache risk through cross-sectional and longitudinal analyses. This study analyzed data from the China Health and Retirement Longitudinal Study (CHARLS) collected between 2015 to 2020, comprising community-dwelling residents > 45 years across 28 provinces in China. The longitudinal component included participants with no history of headache diagnosis in the 2015 cross-sectional survey, who were followed up until 2020. The ratio of actual PEF values to predicted values (PEF% predicted) was used and split into quartiles: Q1 (< 66.0%), Q2 (66.0%–84.1%), Q3 (84.2%–101.5%), and Q4 (≥ 101.6%). In total, 10,917 participants (51.4 % aged >60 years, 43.9% male) were included in the cross-sectional analysis, with 1648 in the headache group and 9269 in the non-headache group.  Higher PEF% predicted was associated with a lower probability of headache (P < 0.05). Compared with the Q1 group, participants in the Q4 group had a lower probability of experiencing headaches (adjusted odds ratio (aOR) = 0.81, 95% CI 0.68–0.96). The longitudinal analysis included 2,428 (46.7%) participants newly diagnosed with headaches by the end of the follow-up period. Higher PEF% predicted was associated with a lower risk of headache (p < 0.05). Compared with the Q1 group, the Q4 group had a lower risk of headache (adjusted hazard ratio (aHR) = 0.80, 95% CI 0.72–0.91). Overall, this study found that a higher PEF% predicted was a protective factor for the occurrence of headache among a middle-aged and elderly population in China. Improving levels of PEF may be important in preventing headaches. Future studies are needed to validate these findings using other indicators of lung function.

Click to read the study in EJMR

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

One in four National Football League (NFL) players who died between 2016-2021 had evidence of chronic traumatic encephalopathy

Brain-predicted age difference may reliably predict dementia progression

Diffusion-weighted imaging may aid in prognostication for intracerebral hemorrhage

Tags: headacheneurologypulmonologyrespirologyspirometry
Previous Post

#VisualAbstract: Personalised Gait Retraining is an Effective Non-Surgical Treatment for Medial Compartment Knee Osteoarthritis

Next Post

Pembrolizumab improves survival in locally advanced head and neck cancer

RelatedReports

Chronic Disease

One in four National Football League (NFL) players who died between 2016-2021 had evidence of chronic traumatic encephalopathy

August 27, 2026
Chronic Disease

Brain-predicted age difference may reliably predict dementia progression

August 19, 2026
No difference in mortality for intensive versus standard reduction in blood pressure in intracerebral hemorrhage: The ATACH-2 trial
Emergency

Diffusion-weighted imaging may aid in prognostication for intracerebral hemorrhage

August 18, 2026
Low free sugar diet reduces hepatic steatosis in nonalcoholic fatty liver disease in adolescent males
Weekly Rewinds

2 Minute Medicine Rewind August 17, 2026

August 17, 2026
Next Post
Elective neck dissection may be unnecessary for adenoid cystic carcinoma

Pembrolizumab improves survival in locally advanced head and neck cancer

USPSTF recommends chemoprevention for women at high risk for breast cancer

Inavolisib lengthens progression-free survival time in HER2-negative advanced breast cancer

Parental conceptions of weight are becoming increasingly inaccurate

Tirzepatide leads to greater weight loss than semaglutide among adults with obesity

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • The 5x-multiplier algorithm reduces opioids prescribed at discharge
  • Historical redlining associated with lower breast cancer screening across urban neighborhoods
  • N-methylaniline exposure identified as likely cause of methemoglobinemia during maritime migration
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.